Tag

Affibody

David Bejker

Affibody and Inmagene announce IND Clearance

March 10, 2021

The US FDA has cleared …

Fredrik Frejd

Affibody and Inmagene announce IND Clearance

February 10, 2021

Affibody and Inmagene Biopharmaceuticals has …

Biovian

Affibody selects Biovian as a CDMO partner for ABY-062

February 9, 2021

Affibody has selected Biovian Oy …

Fredrik Frejd

Affibody terminates program and announces positive data from another

June 15, 2020

Affibody has announced the completion …

David Bejker

Affibody enters partnership with Inmagene

May 15, 2020

Under the terms of the …

David Bejker

Affibody announces Option Exercise by Daewoong

May 4, 2020

Affibody has announced that its …

David Bejker

Affibody and GE Healthcare to collaborate

September 20, 2019

Affibody has announced a strategic …

David Bejker

Affibody announces interim analysis in Phase 2 Psoriasis trial

August 11, 2019

The company has completed a …

Affibody agreement 3P

Affibody in agreement with 3P Biopharmaceuticals

May 27, 2019

The agreement with 3P Biopharmaceuticals …

David Bejker

Affibody announces co-development agreement with Alexion

March 20, 2019

Swedish Affibody and US Alexion …

affibody_lab

Affibody to initiate phase II psoriasis trial

May 12, 2017

Affibody announces that it has …

Nanovector, Affibody to Collaborate

Ellen R. Delisio

December 5, 2014

Norway’s Nordic Nanovector ASA and …

Affibody signs deal with Daiichi Sankyo

August 6, 2013

Stockholm-based Affibody AB announces a …

Affibody wins SwedenBIO Award

May 22, 2013

Swedish biotech company Affibody received …